toad.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Mastodon server operated by David Troy, a tech pioneer and investigative journalist addressing threats to democracy. Thoughtful participation and discussion welcome.

Administered by:

Server stats:

240
active users

#ips

2 posts2 participants0 posts today
UK<p><a href="https://www.europesays.com/uk/302603/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/uk/302603/</span><span class="invisible"></span></a> US ‘non-committal’ on whether level of tariffs with Singapore will stay at 10 per cent: DPM Gan <a href="https://pubeurope.com/tags/GanKimYong" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GanKimYong</span></a> <a href="https://pubeurope.com/tags/IPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPS</span></a> <a href="https://pubeurope.com/tags/Trade" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Trade</span></a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UnitedStates</span></a> <a href="https://pubeurope.com/tags/us" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>us</span></a> <a href="https://pubeurope.com/tags/UsTariffs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UsTariffs</span></a> <a href="https://pubeurope.com/tags/USA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>USA</span></a></p>
The Japan Times<p>A Japanese startup says it has conducted a clinical trial to transplant a sheet of cardiac muscle cells derived from human induced pluripotent stem (iPS) cells into a patient with a heart muscle disease. <a href="https://www.japantimes.co.jp/news/2025/07/29/japan/science-health/ips-trial-heart-treatment/?utm_medium=Social&amp;utm_source=mastodon" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/news/2025/07/</span><span class="invisible">29/japan/science-health/ips-trial-heart-treatment/?utm_medium=Social&amp;utm_source=mastodon</span></a> <a href="https://mastodon.social/tags/japan" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>japan</span></a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>sciencehealth</span></a> <a href="https://mastodon.social/tags/ips" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ips</span></a> <a href="https://mastodon.social/tags/startups" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>startups</span></a> <a href="https://mastodon.social/tags/heartdisease" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>heartdisease</span></a></p>
UK<p><a href="https://www.europesays.com/uk/288034/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/uk/288034/</span><span class="invisible"></span></a> Affordable mid-range with solid selling points – Motorola Moto G56 smartphone review #120 <a href="https://pubeurope.com/tags/120Hz" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>120Hz</span></a> <a href="https://pubeurope.com/tags/Benchmarks" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Benchmarks</span></a> <a href="https://pubeurope.com/tags/FauxLeather" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>FauxLeather</span></a> <a href="https://pubeurope.com/tags/G56" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>G56</span></a> <a href="https://pubeurope.com/tags/GraphicsCard" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GraphicsCard</span></a> <a href="https://pubeurope.com/tags/IP68" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IP68</span></a> <a href="https://pubeurope.com/tags/IP69" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IP69</span></a> <a href="https://pubeurope.com/tags/IPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPS</span></a> <a href="https://pubeurope.com/tags/laptop" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>laptop</span></a> <a href="https://pubeurope.com/tags/Mobile" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Mobile</span></a> <a href="https://pubeurope.com/tags/moto" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>moto</span></a> <a href="https://pubeurope.com/tags/MotoG" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MotoG</span></a> <a href="https://pubeurope.com/tags/MotoG56" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MotoG56</span></a> <a href="https://pubeurope.com/tags/Motorola" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Motorola</span></a> <a href="https://pubeurope.com/tags/MotorolaG56" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MotorolaG56</span></a> <a href="https://pubeurope.com/tags/netbook" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>netbook</span></a> <a href="https://pubeurope.com/tags/notebook" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>notebook</span></a> <a href="https://pubeurope.com/tags/processor" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>processor</span></a> <a href="https://pubeurope.com/tags/reports" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>reports</span></a> <a href="https://pubeurope.com/tags/rest" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>rest</span></a> <a href="https://pubeurope.com/tags/Review" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Review</span></a> <a href="https://pubeurope.com/tags/Reviews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Reviews</span></a> <a href="https://pubeurope.com/tags/smartphone" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>smartphone</span></a> <a href="https://pubeurope.com/tags/Technology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Technology</span></a> <a href="https://pubeurope.com/tags/test" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>test</span></a> <a href="https://pubeurope.com/tags/tests" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>tests</span></a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UK</span></a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UnitedKingdom</span></a></p>
Kevin Karhan :verified:<p><span class="h-card" translate="no"><a href="https://ipv6.social/@miyuru" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>miyuru</span></a></span> <span class="h-card" translate="no"><a href="https://pleroma.tevps.net/users/palfrey" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>palfrey</span></a></span> <span class="h-card" translate="no"><a href="https://mastodon.social/@dwm" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>dwm</span></a></span> because in practice it's easier and cheaper to get a <a href="https://infosec.space/tags/domain" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>domain</span></a> than an <a href="https://infosec.space/tags/IP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IP</span></a> allocation and those are even easier to transfer...</p><ul><li>After all there are even free (Sub-)Domains to choose from.</li></ul><p><a href="https://infosec.space/@kkarhan/114849796648990119" translate="no" rel="nofollow noopener" target="_blank"><span class="invisible">https://</span><span class="ellipsis">infosec.space/@kkarhan/1148497</span><span class="invisible">96648990119</span></a></p><p>Previously, using <a href="https://infosec.space/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> instead of <a href="https://infosec.space/tags/FQDNs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>FQDNs</span></a> was not allowed <em>for very good reasons</em>...<br><a href="https://infosec.space/@kkarhan/114849845399264898" translate="no" rel="nofollow noopener" target="_blank"><span class="invisible">https://</span><span class="ellipsis">infosec.space/@kkarhan/1148498</span><span class="invisible">45399264898</span></a></p>
The Japan Times<p>A team led by a professor at Osaka University's Bioinformatics Center has replicated the mouse embryo implantation process in laboratory equipment with a high success rate. <a href="https://www.japantimes.co.jp/news/2025/07/11/japan/science-health/mouse-embryo-implantation-reproduced/?utm_medium=Social&amp;utm_source=mastodon" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/news/2025/07/</span><span class="invisible">11/japan/science-health/mouse-embryo-implantation-reproduced/?utm_medium=Social&amp;utm_source=mastodon</span></a> <a href="https://mastodon.social/tags/japan" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>japan</span></a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>sciencehealth</span></a> <a href="https://mastodon.social/tags/osakauniversity" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>osakauniversity</span></a> <a href="https://mastodon.social/tags/invitro" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>invitro</span></a> <a href="https://mastodon.social/tags/pregnancy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pregnancy</span></a> <a href="https://mastodon.social/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>medicine</span></a> <a href="https://mastodon.social/tags/ips" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ips</span></a></p>
John<p>Nurses' <a href="https://union.place/tags/unions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>unions</span></a> march on <a href="https://union.place/tags/Paraguay" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Paraguay</span></a> capital, against <a href="https://union.place/tags/privatization" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>privatization</span></a> and lack of funding</p><p><a href="https://publicservices.international/resources/news/paraguay-nurses-win-better-conditions-after-massive-march-against-insecurity-and-privatization?id=15933&amp;lang=en" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">publicservices.international/r</span><span class="invisible">esources/news/paraguay-nurses-win-better-conditions-after-massive-march-against-insecurity-and-privatization?id=15933&amp;lang=en</span></a></p><p><a href="https://union.place/tags/union" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>union</span></a> <a href="https://union.place/tags/UnionStrong" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UnionStrong</span></a> <a href="https://union.place/tags/neoliberalism" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>neoliberalism</span></a> <a href="https://union.place/tags/austerity" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>austerity</span></a> <a href="https://union.place/tags/Asuncion" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Asuncion</span></a> <a href="https://union.place/tags/PSI" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PSI</span></a> <a href="https://union.place/tags/APE" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>APE</span></a> <a href="https://union.place/tags/outsourcing" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>outsourcing</span></a> <a href="https://union.place/tags/IPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPS</span></a> <a href="https://union.place/tags/corruption" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>corruption</span></a></p>
Alo Japan<p><a href="https://www.alojapan.com/1318227/celebrating-swiss-japanese-scientific-ties-at-expo-2025-osaka%ef%bd%9cnews-events-cira/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">alojapan.com/1318227/celebrati</span><span class="invisible">ng-swiss-japanese-scientific-ties-at-expo-2025-osaka%ef%bd%9cnews-events-cira/</span></a> Celebrating Swiss-Japanese Scientific Ties at EXPO 2025 Osaka|News &amp; Events | CiRA <a href="https://channels.im/tags/CiRA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CiRA</span></a> <a href="https://channels.im/tags/iPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>iPS</span></a> <a href="https://channels.im/tags/IPSCell" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPSCell</span></a> <a href="https://channels.im/tags/Kyoto" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Kyoto</span></a> <a href="https://channels.im/tags/KyotoNews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>KyotoNews</span></a> <a href="https://channels.im/tags/KyotoUniversity" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>KyotoUniversity</span></a> <a href="https://channels.im/tags/news" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>news</span></a> <a href="https://channels.im/tags/StemCell" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>StemCell</span></a> <a href="https://channels.im/tags/%E4%BA%AC%E9%83%BD" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>京都</span></a> <a href="https://channels.im/tags/%E4%BA%AC%E9%83%BD%E5%BA%9C" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>京都府</span></a> In a vibrant celebration of international scientific collaboration, the science café “Creating a Healthier You with iPS Cells and Next-Gen Medicine” was held at EXPO 2025 Osaka on June 21-22, 2025. Co-hosted by CiRA, CiRA Foundation, Institute for Regenerative Medicine (IREM) a</p>
The Spamhaus Project<p>Login here: 👉 <a href="https://auth.spamhaus.org" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">auth.spamhaus.org</span><span class="invisible"></span></a></p><p>And review your 'Display Name' and consent to sharing on the leaderboard. </p><p><a href="https://infosec.exchange/tags/CommunityLeaderboard" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CommunityLeaderboard</span></a> <a href="https://infosec.exchange/tags/ThreatIntel" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ThreatIntel</span></a> <a href="https://infosec.exchange/tags/RawSource" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RawSource</span></a> <a href="https://infosec.exchange/tags/Domains" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Domains</span></a> <a href="https://infosec.exchange/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> <a href="https://infosec.exchange/tags/URLs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>URLs</span></a></p>
The Spamhaus Project<p>Get it here ➡️ <a href="https://www.spamhaus.org/blocklists/do-not-route-or-peer/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">spamhaus.org/blocklists/do-not</span><span class="invisible">-route-or-peer/</span></a> </p><p>Remember, this is traffic you do not want to connect with. Not ever. DROP it and move on.</p><p><a href="https://infosec.exchange/tags/DROP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>DROP</span></a> <a href="https://infosec.exchange/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> <a href="https://infosec.exchange/tags/BulletproofHosting" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>BulletproofHosting</span></a> <a href="https://infosec.exchange/tags/ThreatIntel" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ThreatIntel</span></a></p>
Agnieszka Serafinowicz<p><strong>Ten monitor Philipsa może namieszać na&nbsp;rynku. Nowa Evnia dla graczy w&nbsp;cenie, która&nbsp;zaskakuje</strong></p><p>Firma MMD, producent monitorów marki Philips, wprowadza na&nbsp;rynek nowy model z&nbsp;gamingowej serii Evnia 3000: Philips Evnia 27M2N3501PA.<br></p><p>Philips Evnia 27M2N3501PA to&nbsp;27-calowy monitor o&nbsp;rozdzielczości QHD, który&nbsp;oferuje odświeżanie do&nbsp;260 Hz i&nbsp;szereg funkcji dla graczy, a&nbsp;jego sugerowana cena detaliczna wynosi 1058 zł.</p><p>Obraz nowego monitora prezentuje 27-calowa matryca IPS o&nbsp;rozdzielczości 2560 x&nbsp;1440 pikseli.&nbsp; Jej natywna częstotliwość odświeżania wynosi 240 Hz, jednak dzięki funkcji DP Overclock można ją&nbsp;podnieść do&nbsp;260 Hz.&nbsp; Czas reakcji panelu to&nbsp;1 ms (GtG), a&nbsp;w&nbsp;specjalnym trybie Smart MBR skraca się on&nbsp;do&nbsp;0,3 ms.&nbsp; Takie parametry, uzupełnione o&nbsp;technologię Adaptive-Sync, mają zapewnić płynny obraz pozbawiony smużenia, co&nbsp;docenią szczególnie miłośnicy dynamicznych gier kompetytywnych.</p> <a href="https://imagazine.pl/wp-content/uploads/2025/06/27M2N3501PA_FTL-SC.jpg" rel="nofollow noopener" target="_blank"></a> <a href="https://imagazine.pl/wp-content/uploads/2025/06/27M2N3501PA_IO_H.jpg" rel="nofollow noopener" target="_blank"></a> <a href="https://imagazine.pl/wp-content/uploads/2025/06/27M2N3501PA_F-H-IMAGE.jpg" rel="nofollow noopener" target="_blank"></a> <p><br></p> <p>Oprócz wysokich parametrów technicznych, producent wyposażył monitor w&nbsp;dodatkowe funkcje z&nbsp;myślą o&nbsp;graczach.&nbsp; Wśród nich znalazły się m.in.&nbsp;Smart Sniper, która&nbsp;pozwala przybliżyć fragment ekranu w&nbsp;celu łatwiejszego celowania, Stark ShadowBoost poprawiająca widoczność w&nbsp;ciemnych lub prześwietlonych lokacjach oraz&nbsp;Smart Crosshair, czyli wyświetlany na&nbsp;stałe celownik, którego&nbsp;kolor dopasowuje się do&nbsp;tła.&nbsp; Ustawieniami monitora można zarządzać z&nbsp;poziomu dedykowanej aplikacji.</p><p><a href="https://imagazine.pl/wp-content/uploads/2025/06/27M2N3501PA_KV_New.jpg" rel="nofollow noopener" target="_blank"></a></p><p>Zadaniem urządzenia jest nie&nbsp;tylko&nbsp;dostarczanie wrażeń z&nbsp;rozgrywki, ale&nbsp;również zapewnienie komfortu użytkowania. Monitor wyposażono w&nbsp;technologie Flicker-free i&nbsp;Low Blue Mode, które ograniczają odpowiednio migotanie obrazu i&nbsp;emisję niebieskiego światła, redukując zmęczenie oczu.&nbsp; Wygodę pracy i&nbsp;gry zapewnia w&nbsp;pełni regulowana podstawa, pozwalająca na&nbsp;zmianę wysokości (130 mm), pochylenia, obrotu oraz&nbsp;ustawienie ekranu w&nbsp;pozycji pionowej (pivot).&nbsp; Producent pomyślał także o&nbsp;aspekcie ekologicznym – opakowanie monitora w&nbsp;100% nadaje się do&nbsp;recyklingu, a&nbsp;obudowa urządzenia została wykonana w&nbsp;85% z&nbsp;plastiku pochodzącego z&nbsp;recyklingu.</p><blockquote><p><a href="https://imagazine.pl/2025/03/24/philips-hue-secure-nowy-wideodzwonek-ujawniony-przez-aktualizacje-aplikacji/" rel="nofollow noopener" target="_blank">Philips Hue Secure – nowy wideodzwonek ujawniony przez&nbsp;aktualizację aplikacji</a></p></blockquote><p></p><p><a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/260-hz/" target="_blank">#260Hz</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/27-cali/" target="_blank">#27Cali</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/adaptive-sync/" target="_blank">#AdaptiveSync</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/dla-graczy/" target="_blank">#dlaGraczy</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/evnia/" target="_blank">#Evnia</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/gaming/" target="_blank">#gaming</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/ips/" target="_blank">#IPS</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/mmd/" target="_blank">#MMD</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/monitor/" target="_blank">#monitor</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/news/" target="_blank">#news</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/philips/" target="_blank">#philips</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://imagazine.pl/tag/qhd/" target="_blank">#QHD</a></p>
Dendrobatus Azureus<p><span class="h-card"><a href="https://polymaths.social/@rl_dane" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>rl_dane</span></a></span> <span class="h-card"><a href="https://polymaths.social/@tripplehelix" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>tripplehelix</span></a></span></p><p>KDE with Touch displays is <em>smooth</em> right? It should be fantastic when you view it from an IPS LED monitor</p><p><a href="https://polymaths.social/tags/kde" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>KDE</span></a> <a href="https://polymaths.social/tags/ips" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPS</span></a> <a href="https://polymaths.social/tags/led" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>LED</span></a> <a href="https://polymaths.social/tags/monitor" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>monitor</span></a> <a href="https://polymaths.social/tags/ui" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UI</span></a></p>
Right News<p>आईपीएस तबादला: बिहार में विधानसभा चुनाव से पहले सात बड़े अफसरों को मिली नई जिम्मेदारी, जानें किसको कहां भेजा <a href="https://mastodon.social/tags/News" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>News</span></a> <a href="https://mastodon.social/tags/IPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPS</span></a> <a href="https://mastodon.social/tags/Transfer" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Transfer</span></a> <a href="https://mastodon.social/tags/Bihar" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Bihar</span></a> <a href="https://mastodon.social/tags/Elections" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Elections</span></a></p><p><a href="https://rightnewsindia.com/state/bihar/ips-transfer-new-responsibility-for-seven-senior-officers-before-assembly-elections-in-bihar/174800/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">rightnewsindia.com/state/bihar</span><span class="invisible">/ips-transfer-new-responsibility-for-seven-senior-officers-before-assembly-elections-in-bihar/174800/</span></a></p>
The Spamhaus Project<p>Big shout out to the latest Threat Intel Community Top10 new entries!! 📣 🤩</p><p>📩 TF0 <br>🌐 mugufinder<br>🌐 Mir Ali Shahidi <br>🌐 Contributor: PG22 <br>🔗 Contributor: IM53 <br>🔗 EGP Abuse Dept. </p><p>A big THANK YOU to all our contributors for your ongoing support &amp; submissions 🙏</p><p>Contributors PG22, IM53 claim your name! </p><p>It only takes a min to review your 'Display Name' and give consent to share it on the leaderboard. </p><p>Login here: 👉 <a href="https://auth.spamhaus.org" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">auth.spamhaus.org</span><span class="invisible"></span></a></p><p><a href="https://infosec.exchange/tags/ThreatIntel" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ThreatIntel</span></a> <a href="https://infosec.exchange/tags/RawSource" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RawSource</span></a> <a href="https://infosec.exchange/tags/Domains" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Domains</span></a> <a href="https://infosec.exchange/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> <a href="https://infosec.exchange/tags/URLs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>URLs</span></a></p>
The Spamhaus Project<p>Get it here ➡️ <a href="https://www.spamhaus.org/blocklists/do-not-route-or-peer/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">spamhaus.org/blocklists/do-not</span><span class="invisible">-route-or-peer/</span></a> </p><p>Remember, this is traffic you do not want to connect with. Not ever. DROP it and move on.</p><p><a href="https://infosec.exchange/tags/DROP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>DROP</span></a> <a href="https://infosec.exchange/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> <a href="https://infosec.exchange/tags/BulletproofHosting" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>BulletproofHosting</span></a> <a href="https://infosec.exchange/tags/ThreatIntel" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ThreatIntel</span></a></p>
The Japan Times<p>A Japanese research team has started a final-stage clinical trial to treat familial Alzheimer's disease patients with a drug discovered through induced pluripotent stem (IPS) cells. <a href="https://www.japantimes.co.jp/news/2025/06/04/japan/science-health/alzheimers-ips-drug-trial/?utm_medium=Social&amp;utm_source=mastodon" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/news/2025/06/</span><span class="invisible">04/japan/science-health/alzheimers-ips-drug-trial/?utm_medium=Social&amp;utm_source=mastodon</span></a> <a href="https://mastodon.social/tags/japan" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>japan</span></a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>sciencehealth</span></a> <a href="https://mastodon.social/tags/alzheimer039s" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>alzheimer039s</span></a> <a href="https://mastodon.social/tags/ips" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ips</span></a></p>
Pick Nick 🇨🇦 (Nasty AF)<p><a href="https://mastodonapp.uk/tags/MNU" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MNU</span></a> and <a href="https://mastodonapp.uk/tags/TOT" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>TOT</span></a> are lucky that <a href="https://mastodonapp.uk/tags/LEI" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>LEI</span></a>, <a href="https://mastodonapp.uk/tags/IPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPS</span></a> and <a href="https://mastodonapp.uk/tags/SOU" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SOU</span></a>' s had such dismal seasons. 38 &amp; 39 points just gets them over the line.<br><a href="https://mastodonapp.uk/tags/fedifc" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>fedifc</span></a></p>
The Spamhaus Project<p>With a +61% ⬆️ increase, 🇺🇸 US-based "charter.com" is #1 for hosting IPs associated with exploited devices: 193, 782 detections over the last 30 days....</p><p>....as well as 167 Spamhaus Blocklist (SBL) listings. </p><p>Spamhaus reputation statistics:<br>👉 <a href="https://www.spamhaus.org/reputation-statistics/networks/exploit/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">spamhaus.org/reputation-statis</span><span class="invisible">tics/networks/exploit/</span></a></p><p>SBL listings:<br>👉 <a href="https://check.spamhaus.org/sbl/listings/charter.com/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/sbl/listing</span><span class="invisible">s/charter.com/</span></a></p><p><a href="https://infosec.exchange/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> <a href="https://infosec.exchange/tags/Exploits" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Exploits</span></a> <a href="https://infosec.exchange/tags/Spamhaus" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Spamhaus</span></a> <a href="https://infosec.exchange/tags/ReputationStatistics" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ReputationStatistics</span></a> <a href="https://infosec.exchange/tags/ThreatIntel" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ThreatIntel</span></a></p>
The Spamhaus Project<p>❗Latest Spamhaus DROP Listings, from the worst of the worst IP traffic: </p><p>SBL678470 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678470" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678470</span></a><br>SBL678435 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678435" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678435</span></a><br>SBL678397 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678397" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678397</span></a><br>SBL678390 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678390" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678390</span></a><br>SBL678365 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678365" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678365</span></a><br>SBL678358 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678358" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678358</span></a><br>SBL678357 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678357" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678357</span></a><br>SBL678356 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678356" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678356</span></a><br>SBL678355 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678355" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678355</span></a><br>SBL678259 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678259" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678259</span></a><br>SBL678229 ➡️ <a href="https://check.spamhaus.org/results?query=SBL678229" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">check.spamhaus.org/results?que</span><span class="invisible">ry=SBL678229</span></a></p><p>⛔️ This is traffic you DO NOT want to connect with.</p><p>Did you know you can use Spamhaus' DROP lists for free? Gain protection from the worst of the worst IP traffic now - access the DROP and ASN-DROP lists here 👇<br><a href="https://www.spamhaus.org/blocklists/do-not-route-or-peer/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">spamhaus.org/blocklists/do-not</span><span class="invisible">-route-or-peer/</span></a></p><p><a href="https://infosec.exchange/tags/DROP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>DROP</span></a> <a href="https://infosec.exchange/tags/IPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPs</span></a> <a href="https://infosec.exchange/tags/BulletproofHosting" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>BulletproofHosting</span></a> <a href="https://infosec.exchange/tags/ThreatIntel" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ThreatIntel</span></a></p>
The Japan Times<p>A research team led by Kyoto University said it has prevented kidney functions from declining in mice using human induced pluripotent stem cells, which may lead to an effective therapy for chronic kidney disease. <a href="https://www.japantimes.co.jp/news/2025/04/23/japan/science-health/ips-cells-kidney-disease-treatment/?utm_medium=Social&amp;utm_source=mastodon" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/news/2025/04/</span><span class="invisible">23/japan/science-health/ips-cells-kidney-disease-treatment/?utm_medium=Social&amp;utm_source=mastodon</span></a> <a href="https://mastodon.social/tags/japan" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>japan</span></a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>sciencehealth</span></a> <a href="https://mastodon.social/tags/ips" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ips</span></a> <a href="https://mastodon.social/tags/kyotouniversity" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>kyotouniversity</span></a> <a href="https://mastodon.social/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>health</span></a></p>
Alo Japan<p><a href="https://www.alojapan.com/1252970/pioneering-a-cure-for-parkinsons-disease-first-allogeneic-ips-cell-based-therapy-demonstrates-safety-and-efficacy%ef%bd%9cnews-events-cira/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">alojapan.com/1252970/pioneerin</span><span class="invisible">g-a-cure-for-parkinsons-disease-first-allogeneic-ips-cell-based-therapy-demonstrates-safety-and-efficacy%ef%bd%9cnews-events-cira/</span></a> Pioneering a Cure for Parkinson’s Disease: First Allogeneic iPS Cell-Based Therapy Demonstrates Safety and Efficacy|News &amp; Events | CiRA <a href="https://channels.im/tags/CiRA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CiRA</span></a> <a href="https://channels.im/tags/iPS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>iPS</span></a> <a href="https://channels.im/tags/IPSCell" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>IPSCell</span></a> <a href="https://channels.im/tags/Kyoto" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Kyoto</span></a> <a href="https://channels.im/tags/KyotoNews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>KyotoNews</span></a> <a href="https://channels.im/tags/KyotoUniversity" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>KyotoUniversity</span></a> <a href="https://channels.im/tags/news" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>news</span></a> <a href="https://channels.im/tags/StemCell" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>StemCell</span></a> <a href="https://channels.im/tags/%E4%BA%AC%E9%83%BD" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>京都</span></a> <a href="https://channels.im/tags/%E4%BA%AC%E9%83%BD%E5%BA%9C" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>京都府</span></a> A team of researchers and clinicians from CiRA and Kyoto University Hospital, led by Professors Jun Takahashi (Department of Clinical Application) and Ryosuke Takahashi (Graduate School of Medicine), has set a new mile…</p>